Search

Search Constraints

You searched for: Author/Creator Weaver, James L.

Search Results

1. Advancing Biosimilar Development Using Pharmacodynamic Biomarkers in Clinical Pharmacology Studies. Issue 1 (31st October 2019)

2. Anti–SARS‐CoV‐2 Repurposing Drug Database: Clinical Pharmacology Considerations. (1st August 2021)

3. Calibration and Validation of a Mechanistic COVID‐19 Model for Translational Quantitative Systems Pharmacology – A Proof‐of‐Concept Model Development for Remdesivir. Issue 4 (29th June 2022)

4. Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development – (III) A Randomized Trial with Interferon Beta‐1a Products. Issue 2 (2nd December 2022)

5. Effects of sedative psychotropic drugs combined with oxycodone on respiratory depression in the rat. Issue 6 (16th June 2021)

7. Investigating the susceptibility of mice to a bacterial challenge after intravenous exposure to durable nanoparticles. (September 2017)

8. Nonclinical Safety Biomarkers of Drug-induced Vascular Injury: Current Status and Blueprint for the Future. (June 2014)

9. Scientific and Regulatory Policy Committee Points-to-consider Paper*: Drug-induced Vascular Injury Associated with Nonsmall Molecule Therapeutics in Preclinical Development: Part 2. Antisense Oligonucleotides. (October 2015)

10. Scientific and Regulatory Policy Committee Points-to-consider Paper*: Drug-induced Vascular Injury Associated with Nonsmall Molecule Therapeutics in Preclinical Development: Part I. Biotherapeutics. (October 2015)